Aumento de transaminasas: una manifestación de distrofia muscular de Duchenne

Avaria, María de los Ángeles; Beytía, María de los Ángeles; Kleinsteuber, Karin; Rodillo, Eliana; Alegría, Sylvia.
Rev. chil. pediatr ; 83(3): 258-261, jun. 2012. tab
Artículo en Español | LILACS | ID: lil-643197

Documentos relacionados

  1. An update on Becker muscular dystrophy.
  2. [Chinese guidelines on the diagnosis of dystrophinopathy].
  3. [Screening for Duchenne muscular dystrophy in newborns in the Ningxia region].
  4. Exon Skipping Therapy.
  5. Development of respiratory care guidelines for Duchenne muscular dystrophy in the UK: key recommendations for clinical practice.
  6. Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy.
  7. Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy.
  8. Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy. Reply.
  9. A DMD case caused by X chromosome rearrangement.
  10. Specificities of the DMD Gene Mutation Spectrum in Russian Patients.